|
Name: 4F-MDMB-BUTICA (methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate
Type: Synthetic Cannabinoid
AKA: 4F-MDMB-BUTICA; 4F-MDMB-BICA
![4F-MDMB-BUTICA (methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate image](https://grammasearch.com/dev/v2/img/syntheticcannabis.png)
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
![4F-MDMB-BUTICA (methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate) image](/dev/v2/pages/pubchem_images/145759603.png)
|
|
IV. History
4F-MDMB-BUTICA, a synthetic cannabinoid, was first synthesized in the 2010s. It reflects ongoing research and development in synthetic cannabinoids with a focus on potent psychoactive effects. Its use in synthetic cannabis products has been linked to health risks, leading to regulatory scrutiny and control measures.
|
|
V. Legal Information
4F-MDMB-BUTICA, a synthetic cannabinoid, is illegal in the US under the Schedule I classification. Many countries have similarly banned it due to severe health risks associated with synthetic cannabinoids. The UNODC has issued alerts on its dangers, prompting global regulatory actions. Trends indicate stricter enforcement and penalties to address the growing concern of synthetic cannabinoid abuse.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
4F-MDMB-BUTICA is a synthetic cannabinoid with potent psychoactive effects. It acts as an upper, increasing heart rate and blood pressure. Short-term use can lead to intense psychoactive effects, while long-term use poses risks of cardiovascular issues and psychological problems. Overdose risks include severe agitation, hallucinations, and cardiovascular effects. Safe use involves cautious dosing and monitoring. Recent research explores its psychoactive effects and associated health risks.  |
|
VII. Psychological Effects
4F-MDMB-BUTICA, a synthetic cannabinoid, affects cannabinoid receptors, leading to altered mood and perception. Immediate effects include euphoria and relaxation, with long-term use potentially causing cognitive impairments and psychological issues. Research focuses on its safety and psychological impact.
 |
|
VIII. Culture
4F-MDMB-BUTICA is a synthetic cannabinoid with no historical or cultural lore, emerging in the recent synthetic drug market. Its cultural significance lies in its use as a legal high and the associated health and legal challenges. Proponents of synthetic cannabinoids highlight their effects and legal status in certain regions, while opponents warn of health risks and unpredictable effects. Its use is primarily recreational, reflecting broader issues in synthetic drug regulation and public health.
 |